Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Editor-in-Chief

ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

Liraglutide-A Novel GLP-1 Analogue

Author(s): Sanjay Kalra, Bharti Kalra and Amit Sharma

Volume 3, Issue 3, 2009

Page: [200 - 204] Pages: 5

DOI: 10.2174/187221409789104719

Price: $65

Abstract

Liraglutide is a novel glucagon-like peptide 1 analogue, which shows promise as a safe, effective therapy for type 2 diabetes. This review discusses the pathophysiology of type 2 diabetes, focusing on the incretin system, and reviews the pharmacology of liraglutide. A concise discussion of preclinical and clinical data is given, highlighting the benefits of liraglutide with respect to glycaemic control, weight modulation and extraglycaemic effects. This article also review some of recent patents related to the field.

Keywords: Liraglutide, type 2 diabetes, incretins, glucagon like peptide-1 (GLP-1)


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy